Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

23 May, 2017, 05:15 ET CLJI Worldwide Trial inscribe al primer paciente en el estudio clínico de VIBLOK contra el Herpes Simplex Virus

El estudio patrocinado por CLJI Worldwide evalúa la seguridad y el rendimiento de VIBLOK como una barrera para la transmisión del virus en adultos...


23 May, 2017, 03:00 ET Das Istituto Italiano di Tecnologia (IIT) und Movendo Technology starten die Produktion ihrer ersten 30 rehabilitativen Hunova Roboter

Hunova, das erste robotische Fitnessgerät für Rehabilitation und Ermittlung des funktionellen motorischen Gefühls der unteren Gliedmaßen und...


23 May, 2017, 03:00 ET IIT y Movendo Technology inician la producción de sus robots de rehabilitación Hunova

- Istituto Italiano di Tecnologia (IIT) y Movendo Technology inician la producción de sus primeros 30 robots de rehabilitación Hunova Hunova,...


23 May, 2017, 03:00 ET L'Istituto Italiano di Tecnologia (IIT) et Movendo Technology lancent la production de leurs 30 premiers robots de rééducation Hunova

Hunova, le premier robot de gymnastique pour la rééducation et d'évaluation de la fonctionnalité motrice et sensitive des membres inférieurs et...


23 May, 2017, 02:48 ET NeuroVive to Continue NeuroSTAT® Clinical Development After Positive Outcome in Preclinical and Clinical TBI Studies

NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced positive results from clinical and preclinical studies with its...


23 May, 2017, 01:30 ET Atox Bio's Reltecimod Passes Futility Analysis in Phase 3 ACCUTE Study; Trial Continues as Planned

Atox Bio today announced that the Phase 3 ACCUTE study, evaluating Reltecimod (previously AB103) in patients with Necrotizing Soft Tissue...


22 May, 2017, 17:45 ET Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

- Kevzara is now available to U.S. patients Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food...


22 May, 2017, 16:05 ET Windtree Receives SBIR Grant in Continued Support of AEROSURF® Phase 2b Clinical Trial

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory...


22 May, 2017, 15:00 ET Experimental Therapy for Immune Diseases Hits Achilles Heel of Activated T cells

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death...


22 May, 2017, 15:00 ET New Findings About Alzheimer's Protein Could Lead to New Drug Treatments

Scientists at the Fisher Center for Alzheimer's Research in New York, led by Nobel Laureate Dr. Paul Greengard, have identified new ways in which a...


22 May, 2017, 15:00 ET ASCO and the CAP Invite Comment on Focused Update to HER2 Testing Guideline in Breast Cancer

Draft recommendations as part of a focused update to the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP)...


22 May, 2017, 11:00 ET Starting Statins in Older Patients Not Effective as Preventive Care

Statins are increasingly prescribed to geriatric patients to stave off premature death from heart disease despite a lack of evidence that this...


22 May, 2017, 11:00 ET Symic Bio Secures $30 Million Series B Financing and Provides SB-030 Program Update

Symic Bio, a biopharmaceutical company developing novel matrix regulator therapeutics, today announced the successful completion of a $30 million...


22 May, 2017, 09:15 ET Big Data Yields Big Insights for Treatment of Central Sleep Apnea

According to a new ResMed-sponsored (NYSE:RMD) study, people with treatment-emergent central sleep apnea (CSA) have a significantly greater risk of...


22 May, 2017, 09:15 ET CollPlant Extends its European Distribution Network With Signing of New Distribution Agreement in Turkey for Vergenix®FG Wound Treatment

CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human "rhCollagen")...


22 May, 2017, 09:00 ET ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes

ViaCyte, Inc., a privately-held leading regenerative medicine company, announced today that the U.S. Food and Drug Administration (FDA) has allowed...


22 May, 2017, 09:00 ET JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes

ViaCyte, Inc., a privately-held leading regenerative medicine company, and JDRF, the leading global organization funding type 1 diabetes research,...


22 May, 2017, 09:00 ET Viriom to Present Results of Pre-Clinical Pharmacokinetic Studies with Elsulfavirine and VM1500A Long Acting Injectable Formulations at the International AIDS Society (IAS) Conference 2017

Viriom Inc. today announced that the data from pre-clinical studies of Elsulfavirine/VM1500A Long Acting Injectable Formulations will be presented...


22 May, 2017, 09:00 ET Philips-sponsored clinical study demonstrates significant breakthrough for COPD treatment

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT)...